Covered recipient · General Payments record
WHITNEY S DENTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,426.89
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $529.32 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $167.52 | 7 |
| PFIZER INC. | $94.31 | 5 |
| Novo Nordisk AS | $84.96 | 5 |
| GlaxoSmithKline, LLC. | $50.98 | 3 |
| Astellas Pharma US Inc | $40.38 | 2 |
| Abbott Laboratories | $31.54 | 2 |
| Dynavax Technologies Corporation | $23.26 | 1 |
| Amgen Inc. | $18.34 | 1 |
| SANOFI-AVENTIS U.S. LLC | $18.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.41 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912538 | CMS |
| Abbott Laboratories | $13.13 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912540 | CMS |
| ABBVIE INC. | $33.28 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625918 | CMS |
| ABBVIE INC. | $33.89 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625920 | CMS |
| ABBVIE INC. | $6.04 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625922 | CMS |
| ABBVIE INC. | $33.82 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625924 | CMS |
| ABBVIE INC. | $31.51 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625926 | CMS |
| ABBVIE INC. | $14.09 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625928 | CMS |
| ABBVIE INC. | $14.89 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103625930 | CMS |
| Amgen Inc. | $18.34 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115564350 | CMS |
| Astellas Pharma US Inc | $20.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139340692 | CMS |
| Astellas Pharma US Inc | $20.38 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139375365 | CMS |
| Dynavax Technologies Corporation | $23.26 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082147899 | CMS |
| GlaxoSmithKline, LLC. | $18.28 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116476434 | CMS |
| GlaxoSmithKline, LLC. | $18.29 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116430559 | CMS |
| GlaxoSmithKline, LLC. | $14.41 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116382694 | CMS |
| Novo Nordisk Inc | $13.20 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096730708 | CMS |
| Novo Nordisk Inc | $18.58 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097138202 | CMS |
| Novo Nordisk Inc | $13.55 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097729012 | CMS |
| Novo Nordisk Inc | $21.36 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096668037 | CMS |
| Novo Nordisk Inc | $18.27 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097229251 | CMS |
| PFIZER INC. | $20.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131171599 | CMS |
| PFIZER INC. | $17.69 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131474179 | CMS |
| PFIZER INC. | $13.27 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131934664 | CMS |
| PFIZER INC. | $23.11 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131943576 | CMS |
| PFIZER INC. | $19.98 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131166307 | CMS |
| SANOFI-AVENTIS U.S. LLC | $18.03 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139744016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.